United Kingdom · Question · Written question
UIN 158930
Tixagevimab/cilgavimab
Introduced
25 April 2022
Last action
28 April 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 April 2022
Summary
To ask the Secretary of State for Health and Social Care, what timeframe the UK Health Security Agency are working to in order to assess the effectiveness of Evusheld against the Omicron variant of covid-19.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 April 2022
Written question
To ask the Secretary of State for Health and Social Care, what timeframe the UK Health Security Agency are working to in order to assess the effectiveness of Evusheld against the Omicron variant of covid-19.
Source: Commons
28 April 2022
Answer
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-04-25/158930
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1459979
- uk · wq-1459979 · source updated 28 April 2022